oxymatrine has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y; Li, X; Wang, Q; Xu, J; Zhang, D; Zhang, X | 1 |
| Guo, Y; Hu, W; Huang, W; Pan, X; Sun, X; Wu, C; Xia, P | 1 |
2 other study(ies) available for oxymatrine and Prostatic Neoplasms
| Article | Year |
|---|---|
Comprehensive two-dimensional PC-3 prostate cancer cell membrane chromatography for screening anti-tumor components from Radix Sophorae flavescentis.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Membrane; China; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Flavonoids; Humans; Male; Matrines; Propiophenones; Prostatic Neoplasms; Quinolizines; Sophora | 2017 |
Oxymatrine inhibits the proliferation of prostate cancer cells in vitro and in vivo.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice, Nude; Prostate; Prostatic Neoplasms; Quinolizines; Sophora | 2015 |